| |
|
|
|
Neu Base Therapeutics Inc  
|
|
9.48 -0.15 (-0.02%) |
02-26 16:00 |
|
Open: |
9.69 |
Pre close: |
9.63 |
Target:
|
13.24 
|
|
High: |
9.8 |
Low: |
9.03 |
Resistance:
|
11.33
12.89
|
|
Volume: |
229,661 |
Market Cap: |
220M |
Support:
|
8.81
7.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.96
 |
MACD |
MACD(12,26):
|
0.25 |
|
MA(20): |
10.61 |
Signal(12,26,9): |
0.55 |
|
MA(100): |
8.62 |
Stochastic Oscillator |
%K(14,3):
|
14.48 |
|
MA(250): |
8.23 |
%D(3): |
21.52 |
|
Average Volume(K) |
3-Month: |
34079
|
52-Week |
High:
|
12.89 |
|
10-Days: |
26019 |
Low: |
4.52 |
|
RSI |
RSI(14):
|
44.18 |
Change(%): |
27.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.260 |
Return on Equity (ttm) |
-84.1 |
Shares Out. (M) |
23.12 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-45.4 |
Shares Float (M) |
16.92 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.07 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
31.94 |
|
Forward EPS |
-3.260 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1110 |
|
Book Value (p.s.) |
0.590 |
EBITDA (p.s.) |
-0.726 |
P/E |
-2.91 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
16.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.71 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.38 |
P/CF |
-20.46 |
|
|
|
|
|
|
